Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps

被引:4
|
作者
Ramkumar, Shreya P. [1 ,2 ]
Lal, Devyani [1 ]
Miglani, Amar [1 ]
机构
[1] Mayo Clin Hosp, Dept Otolaryngol Head & Neck Surg, Phoenix, AZ USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
来源
FRONTIERS IN ALLERGY | 2023年 / 4卷
关键词
chronic rhinosinusitis (CRS); shared decision making; biologics; nasal polyps (NP); treatment; ENDOSCOPIC SINUS SURGERY; IN-OFFICE TREATMENT; ADULT CHRONIC RHINOSINUSITIS; HEALTH OUTCOMES; ADHERENCE; IMPLANTS; BARRIERS; EFFICACY; CORTICOSTEROIDS; COMPLICATIONS;
D O I
10.3389/falgy.2023.1137907
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Shared decision-making is an approach where physicians and patients work together to determine a personalized treatment course. Such an approach is integral to patient-centered care in chronic rhinosinusitis with nasal polyps (CRSwNP). CRSwNP is a chronic inflammatory condition of the sinonasal cavity that can severely impact physical health, smell, and quality of life (QOL). Traditional standard-of-care treatment options include topical (i.e. sprays) and oral corticosteroids and endoscopic sinus surgery, but more recently, novel corticosteroid delivery methods (i.e. high volume irrigations, recently-approved exhalation breath-powered delivering devices, and drug-eluting steroid implants) and 3 new FDA approved biologics directed against type II immunomodulators have become available. The availability of these therapeutics offers exciting new opportunities in CRSwNP management but requires personalized and shared-decision making as each modality has variable impacts on CRSwNP and related comorbid conditions. Studies have published treatment algorithms, but the practical use of these lean guidelines is heavily influenced by the lens of the treating physician, the most common being otolaryngologists and allergy immunologists. Clinical equipoise occurs when there is no basis for one intervention to be regarded as "better" than another. While most guidelines, in general, support the use of topical corticosteroids with or without oral corticosteroids followed by ESS for the majority of unoperated CRSwNP patients, there are situations of clinical equipoise that arise particularly in CRSwNP who have failed surgery or those with severe comorbid conditions. In the shared decision-making process, clinicians and patients must consider symptomatology, goals, comfort, compliance, treatment efficacy, and treatment cost when determining the initial choice of therapy and escalation of therapy with the potential use of multiple modalities for recalcitrant CRSwNP. A summary of salient considerations that might constitute shared decision-making is presented in this summary.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics
    Hoffmann, Anna S.
    Betz, Christian S.
    Boescke, Robert
    Weber, Rainer K.
    HNO, 2024, 72 (04) : 225 - 230
  • [2] A new treatment for chronic rhinosinusitis with nasal polyps
    Stevens, Whitney W.
    LANCET, 2019, 394 (10209): : 1595 - 1597
  • [3] Treatment options for chronic rhinosinusitis with nasal polyps
    V. Wallace, Dana
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (06) : 450 - 460
  • [4] Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making
    Otten, Josje
    van der Lans, Rik
    de Corso, Eugenio
    Dziadziulia, Kanstantsin
    Hilvering, Bart
    Weersink, Els
    Bonini, Matteo
    Hagemann, Jan
    Thaitrakool, Wanrawee
    Montuori, Claudio
    Klimek, Ludger
    Reitsma, Sietze
    Fokkens, Wytske
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (08) : 1041 - 1049
  • [5] Chronic Rhinosinusitis with Nasal Polyps
    Hopkins, Claire
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 55 - 63
  • [6] Chronic Rhinosinusitis with Nasal Polyps
    Stevens, Whitney W.
    Schleimer, Robert P.
    Kern, Robert C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (04): : 565 - +
  • [7] Treatment Decision-Making Among Chinese Americans With Chronic Rhinosinusitis
    Hur, Kevin
    Gao, Jaynelle
    Adili, Amila
    Tam, Benjamin
    Herrera, Kevin
    Rice, Dale
    Wrobel, Bozena
    Wu, Shinyi
    LARYNGOSCOPE, 2025,
  • [8] Treatment decision-making among Asian Americans with chronic rhinosinusitis
    Reyes Orozco, Francis
    Gao, Jaynelle
    Hur, Kevin
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (12) : 1558 - 1561
  • [9] Mepolizumab for the treatment of chronic rhinosinusitis with nasal polyps in adults
    Neposlan, Josh
    Sowerby, Leigh J.
    Biadsee, Ameen
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (02) : 109 - 118
  • [10] Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
    Kartush, Alison G.
    Schumacher, Jane K.
    Shah, Rachna
    Patadia, Monica O.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2019, 33 (02) : 203 - 211